BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17343811)

  • 21. Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.
    Singh-Franco D; Robles G; Gazze D
    Clin Ther; 2007 Apr; 29(4):535-62. PubMed ID: 17617279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled insulin for diabetes mellitus.
    McMahon GT; Arky RA
    N Engl J Med; 2007 Feb; 356(5):497-502. PubMed ID: 17267909
    [No Abstract]   [Full Text] [Related]  

  • 23. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
    Ryan GJ; Jobe LJ; Martin R
    Clin Ther; 2005 Oct; 27(10):1500-12. PubMed ID: 16330288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study.
    Israël-Bultman H; Hyllested-Winge J; Kolaczynski M; Steindorf J; Garon J
    Clin Ther; 2011 Mar; 33(3):346-57. PubMed ID: 21600387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin therapy in type 2 diabetes.
    Davis T; Edelman SV
    Med Clin North Am; 2004 Jul; 88(4):865-95, x. PubMed ID: 15308383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral drugs for diabetes--update of current use and availability].
    Niskanen L
    Duodecim; 2004; 120(8):983-90. PubMed ID: 15185512
    [No Abstract]   [Full Text] [Related]  

  • 27. Diabetes mellitus management in general practice: where are we?
    Staff M
    Aust Fam Physician; 1999 Aug; 28(8):775. PubMed ID: 10495524
    [No Abstract]   [Full Text] [Related]  

  • 28. Comment on Publications from OpT2mise Study.
    Milenkovic T; Kocova M; Krstevska B; Pemovska G; Smokovski I
    Diabetes Technol Ther; 2016 Jul; 18(7):446-7. PubMed ID: 27043789
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhaled insulin (exubera).
    Med Lett Drugs Ther; 2006 Jul; 48(1239):57-8. PubMed ID: 16841019
    [No Abstract]   [Full Text] [Related]  

  • 30. Update in diabetes management.
    Cranwell-Bruce LA
    Medsurg Nurs; 2009; 18(1):51-3; quiz 54. PubMed ID: 19331300
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral antidiabetic agents: 2004.
    Lebovitz HE
    Med Clin North Am; 2004 Jul; 88(4):847-63, ix-x. PubMed ID: 15308382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A patient's opinion of unmet need.
    Hernandez M; Mehr SR
    Am J Manag Care; 2014 May; 20(8 Spec No.):E16. PubMed ID: 25617936
    [No Abstract]   [Full Text] [Related]  

  • 33. Beyond insulin: what else might help?
    Scheiner G
    Diabetes Self Manag; 2014; 31(1):30, 32-4. PubMed ID: 24640060
    [No Abstract]   [Full Text] [Related]  

  • 34. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M; Lam S
    Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exenatide once weekly in type 2 diabetes mellitus.
    Bischoff LA; Jabbour SA; Miller JL
    Expert Opin Pharmacother; 2011 Jun; 12(8):1297-1303. PubMed ID: 21548720
    [No Abstract]   [Full Text] [Related]  

  • 36. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
    Linnebjerg H; Kothare PA; Skrivanek Z; de la Peña A; Atkins M; Ernest CS; Trautmann ME
    Diabet Med; 2006 Mar; 23(3):240-5. PubMed ID: 16492205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What about insulin as an immediate first step for type 2 diabetes?
    Rolla AR
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():19-22. PubMed ID: 19817780
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diabetes experts evaluate therapy with modern insulin analogs positively (interview by Dr. Silke Wedekind)].
    Renner R; Lundershausen R
    MMW Fortschr Med; 2013 May; 155(9):66-7. PubMed ID: 23951666
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.
    Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG
    Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785
    [No Abstract]   [Full Text] [Related]  

  • 40. Byetta update: what we've learned from experience.
    Cornell S; Todd T
    Diabetes Self Manag; 2010; 27(2):28, 30-1. PubMed ID: 20405747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.